Artikel
Lizenziert
Nicht lizenziert
Erfordert eine Authentifizierung
Adiposopathy in cancer and (cardio)metabolic diseases: an endocrine approach – Part 2
-
Gérard S. Chetrite
Veröffentlicht/Copyright:
6. März 2015
Published Online: 2015-3-6
Published in Print: 2015-1-1
©2015 by De Gruyter
Sie haben derzeit keinen Zugang zu diesem Inhalt.
Sie haben derzeit keinen Zugang zu diesem Inhalt.
Artikel in diesem Heft
- Frontmatter
- Editorial Preface
- Adiposopathy in cancer and (cardio)metabolic diseases: an endocrine approach – Part 2
- Topic 1: Impact of Adiposopathy in Tumoral Disease: Endocrine and Clinical Aspects
- Review Articles
- Obesity and cancer
- Adipose tissue dysfunction and its effects on tumor metabolism
- Local adipocyte cancer cell paracrine loop: can “sick fat” be more detrimental?
- Adipose tissue, obesity and adipokines: role in cancer promotion
- Obesity-related proliferative diseases: the interaction between adipose tissue and estrogens in post-menopausal women
- Molecular cues on obesity signals, tumor markers and endometrial cancer
Artikel in diesem Heft
- Frontmatter
- Editorial Preface
- Adiposopathy in cancer and (cardio)metabolic diseases: an endocrine approach – Part 2
- Topic 1: Impact of Adiposopathy in Tumoral Disease: Endocrine and Clinical Aspects
- Review Articles
- Obesity and cancer
- Adipose tissue dysfunction and its effects on tumor metabolism
- Local adipocyte cancer cell paracrine loop: can “sick fat” be more detrimental?
- Adipose tissue, obesity and adipokines: role in cancer promotion
- Obesity-related proliferative diseases: the interaction between adipose tissue and estrogens in post-menopausal women
- Molecular cues on obesity signals, tumor markers and endometrial cancer
